Found: 59
Select item for more details and to access through your institution.
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6782, doi. 10.1007/s00415-024-12638-0
- By:
- Publication type:
- Article
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA).
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6801, doi. 10.1007/s00415-024-12621-9
- By:
- Publication type:
- Article
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6773, doi. 10.1007/s00415-024-12610-y
- By:
- Publication type:
- Article
Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue.
- Published in:
- Nutrients, 2024, v. 16, n. 18, p. 3100, doi. 10.3390/nu16183100
- By:
- Publication type:
- Article
Comparing face-to-face and videoconference assessment of the Brief Repeatable Battery of Neuropsychological Tests in people with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1337, doi. 10.1177/13524585231192469
- By:
- Publication type:
- Article
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2243, doi. 10.1177/13524585221114007
- By:
- Publication type:
- Article
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 93, doi. 10.1177/13524585211005657
- By:
- Publication type:
- Article
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 430, doi. 10.1177/1352458520974366
- By:
- Publication type:
- Article
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 9, p. 1289, doi. 10.1177/1352458516677592
- By:
- Publication type:
- Article
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 4, p. 483, doi. 10.1002/ana.26322
- By:
- Publication type:
- Article
Prognostic indicators in pediatric clinically isolated syndrome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1692, doi. 10.3390/biomedicines11061692
- By:
- Publication type:
- Article
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54153-7
- By:
- Publication type:
- Article
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 3, p. 1193, doi. 10.1007/s40120-022-00364-6
- By:
- Publication type:
- Article
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients.
- Published in:
- Nutrients, 2017, v. 9, n. 7, p. 783, doi. 10.3390/nu9070783
- By:
- Publication type:
- Article
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 6, p. 1, doi. 10.1111/ene.16250
- By:
- Publication type:
- Article
Italian consensus on treatment of spasticity in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2020, v. 27, n. 3, p. 445, doi. 10.1111/ene.14110
- By:
- Publication type:
- Article
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222012
- By:
- Publication type:
- Article
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211019574
- By:
- Publication type:
- Article
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211019574
- By:
- Publication type:
- Article
Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2023, v. 9, n. 1, p. 1, doi. 10.1177/20552173221144229
- By:
- Publication type:
- Article
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1768, doi. 10.3390/jcm12051768
- By:
- Publication type:
- Article
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 16, p. 4643, doi. 10.3390/jcm11164643
- By:
- Publication type:
- Article
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 6, p. 1160, doi. 10.3390/jcm10061160
- By:
- Publication type:
- Article
Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease.
- Published in:
- Journal of Neuromuscular Diseases, 2021, v. 8, n. 6, p. 979, doi. 10.3233/JND-210663
- By:
- Publication type:
- Article
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 1, p. 45, doi. 10.1007/s10072-022-06402-3
- By:
- Publication type:
- Article
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 11, p. 6415, doi. 10.1007/s10072-022-06211-8
- By:
- Publication type:
- Article
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 4, p. 2601, doi. 10.1007/s10072-021-05608-1
- By:
- Publication type:
- Article
Correction to: Disability assessment using Google Maps.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Disability assessment using Google Maps.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 2, p. 1007, doi. 10.1007/s10072-021-05389-7
- By:
- Publication type:
- Article
Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases.
- Published in:
- European Journal of Ophthalmology, 2012, v. 22, n. 4, p. 661, doi. 10.5301/ejo.5000098
- By:
- Publication type:
- Article
Nociplastic Pain in Multiple Sclerosis Spasticity: Dermatomal Evaluation, Treatment with Intradermal Saline Injection and Outcomes Assessed by 3D Gait Analysis: Review and a Case Report.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 13, p. 7872, doi. 10.3390/ijerph19137872
- By:
- Publication type:
- Article
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 15, p. 8163, doi. 10.3390/ijerph18158163
- By:
- Publication type:
- Article
Therapeutic Plasmapheresis: A Revision of Literature.
- Published in:
- Kidney & Blood Pressure Research, 2023, v. 48, n. 1, p. 66, doi. 10.1159/000528556
- By:
- Publication type:
- Article
Integrated Cognitive and Neuromotor Rehabilitation in Multiple Sclerosis: A Pragmatic Study.
- Published in:
- Frontiers in Behavioral Neuroscience, 2018, p. 1, doi. 10.3389/fnbeh.2018.00196
- By:
- Publication type:
- Article
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
- Published in:
- Infezioni in Medicina, 2014, v. 22, n. 4, p. 331
- By:
- Publication type:
- Article
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Radiological Reporting Systems in Multiple Sclerosis.
- Published in:
- Applied Sciences (2076-3417), 2024, v. 14, n. 13, p. 5626, doi. 10.3390/app14135626
- By:
- Publication type:
- Article
Intracranial extension of orbital inflammatory pseudotumor: a case report and literature review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 5074, doi. 10.1007/s00415-024-12448-4
- By:
- Publication type:
- Article
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 7, p. 4495, doi. 10.1007/s00415-024-12360-x
- By:
- Publication type:
- Article
Late-onset multiple sclerosis: disability trajectories in relapsing–remitting patients of the Italian MS Registry.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 4, p. 1630, doi. 10.1007/s00415-023-12152-9
- By:
- Publication type:
- Article
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 3, p. 1150, doi. 10.1007/s00415-023-12137-8
- By:
- Publication type:
- Article
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 2, p. 699, doi. 10.1007/s00415-023-12084-4
- By:
- Publication type:
- Article
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 10, p. 4687, doi. 10.1007/s00415-023-11820-0
- By:
- Publication type:
- Article
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 10, p. 3008, doi. 10.1007/s00415-020-09959-1
- By:
- Publication type:
- Article
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 12, p. 3098, doi. 10.1007/s00415-019-09531-6
- By:
- Publication type:
- Article